2021 Access to Medicine Index Presentation and Q&A - hosted by Handelsbanken

Handelsbanken, a Swedish bank with a large presence in the Nordic region, will host a webinar largely for Nordic investors on the results of the 2021 Access to Medicine Index. The 1-hour webinar will include a presentation from Mara Lilley, followed by a Q&A with Mara and Damiano de Felice, moderated by Mattias Häggblom, Equity Research Analyst at Handelsbanken.

In her presentation, Mara will discuss:

• The mission of the Access to Medicine Foundation and how the Foundation works with investors

• The scope and structure of the 2021 Index

• Key findings across the 3 technical areas of the report: Governance of Access, Research & Development and Product Delivery

The Q&A discussion will cover a number of topics, including:

• The materiality of access to medicine

• Industry trends, progress and opportunities regarding access to medicine 

• The role of pharmaceutical companies in responding to COVID-19 and preparing for future pandemics

• The role of investors in engaging pharmaceutical companies on access to medicine

About the 2021 Access to Medicine Index

The Access to Medicine Foundation published the 7th Access to Medicine Index on 26 January 2021. The Index reports how 20 pharma companies make medicines, vaccines and diagnostics more accessible for people in low- and middle-income countries. It ranks them on their efforts to improve access to medicine, identifies best practices, highlights where progress is being made and uncovers where critical action is still required. 

The Access to Medicine Index is endorsed by more than 100 investors, collectively managing assets worth over USD 18 trillion. It is published every two years by the Access to Medicine Foundation.

The latest paediatric finding from the 2021 Access to Medicine Index investigates the current actions of the pharmaceutical companies assessed in the 2021 Access to Medicine Index to develop and deploy treatments aimed specifically at children under 12.